17-61456674-C-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP3PP5
The NM_001321120.2(TBX4):c.184C>T(p.Gln62*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001321120.2 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
- coxopodopatellar syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive ameliaInheritance: AR Classification: MODERATE, LIMITED Submitted by: G2P, Ambry Genetics
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1211890Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 591972
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Coxopodopatellar syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at